Through genetic, clinical, and biochemical analyses, we further characterize the phenotypic spectrum of GOT2 deficiency.<h4>Results</h4>Most patients exhibited progressive neurodevelopmental delay, severe to profound intellectual disability, infantile epilepsy, progressive microcephaly, and hypotonia evolving into spasticity with axial hypotonia. This evidence concerns the gene GOT2 and Intellectual disability.